Sunday, October 17, 2021 10:37:57 PM
Looking at the technical price action
about AVXL is not 'off topic' here but I hesitate to post alot of charts and alot of detail TA explanations here because it could start to dominate the forum. If most people here are more interested in the fundamental analysis of good science people, which I am too, then I'd rather see the forum receive the attention of those people like falconer and Biostockclub,and some others.
If you want to talk TA in greater detail, we can avoid being censored at my forum (search 123)
---------------------------------------------
but briefly, As the great pullback from 31 and 28 came down, the TA target retrace was looking at the 21-19 area to hold.But price 'bottomed' so far at the 16.50 area. Rally bounces since then have capped at 21,20.65. and 19.80. and fallen down to the 17-16.75 'bottom zone' Now the latest breakout rally capped at 18.20,
are there any meaningful patterns in the price action ?
Lower highs so far. and a retest of the Bottom zone(16.80) Now the ongoing pullback from 18.20 is looking to find support. So what happened to the rally targets above 20? The downward pressure has not allowed rallys to hit 20 dollars yet. You could say that the grand downwave pullback proccess is still ongoing . The big chart can be examined from the 31 and 28 tops to the bottoms. A real breakout rally pattern has to get back up to retest the 20 area and try and reach 22/23/24. The target is still on the big chart picture. but right now, the price action is still looking to stabilize the bottom zone.
Trying to get away from the bottom
about AVXL is not 'off topic' here but I hesitate to post alot of charts and alot of detail TA explanations here because it could start to dominate the forum. If most people here are more interested in the fundamental analysis of good science people, which I am too, then I'd rather see the forum receive the attention of those people like falconer and Biostockclub,and some others.
If you want to talk TA in greater detail, we can avoid being censored at my forum (search 123)
---------------------------------------------
but briefly, As the great pullback from 31 and 28 came down, the TA target retrace was looking at the 21-19 area to hold.But price 'bottomed' so far at the 16.50 area. Rally bounces since then have capped at 21,20.65. and 19.80. and fallen down to the 17-16.75 'bottom zone' Now the latest breakout rally capped at 18.20,
are there any meaningful patterns in the price action ?
Lower highs so far. and a retest of the Bottom zone(16.80) Now the ongoing pullback from 18.20 is looking to find support. So what happened to the rally targets above 20? The downward pressure has not allowed rallys to hit 20 dollars yet. You could say that the grand downwave pullback proccess is still ongoing . The big chart can be examined from the 31 and 28 tops to the bottoms. A real breakout rally pattern has to get back up to retest the 20 area and try and reach 22/23/24. The target is still on the big chart picture. but right now, the price action is still looking to stabilize the bottom zone.
Trying to get away from the bottom
Recent AVXL News
- Form 8-K - Current report • Edgar (US Regulatory) • 05/22/2026 12:15:26 PM
- Anavex Life Sciences Receives Expected Nasdaq Delinquency Notification • GlobeNewswire Inc. • 05/22/2026 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/15/2026 08:15:25 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 05/14/2026 08:15:30 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 05/11/2026 08:30:22 PM
- CEO Transition and Delayed SEC Filing Put Anavex (AVXL) Leadership Changes in Focus • IH Market News • 05/06/2026 02:52:36 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/06/2026 11:04:59 AM
- Anavex Life Sciences Board of Directors Appoints Former Senior Vice President of Clinical Development Terrie Kellmeyer, PhD, as Interim Chief Executive Officer • GlobeNewswire Inc. • 05/06/2026 11:00:00 AM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 05/01/2026 11:18:47 PM
- Anavex Life Sciences Highlights New Scientific Findings on Shared Biology Between Autism and Alzheimer’s Disease • GlobeNewswire Inc. • 04/14/2026 11:30:00 AM
- Anavex Life Sciences to Present at the 25th Annual Needham Virtual Healthcare Conference • GlobeNewswire Inc. • 04/07/2026 11:30:00 AM
- Anavex withdraws EU approval filing for Alzheimer’s therapy • IH Market News • 03/30/2026 12:39:26 PM
- Anavex Life Sciences Provides Comprehensive Regulatory Update • GlobeNewswire Inc. • 03/30/2026 11:30:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/25/2026 08:06:00 PM
- Anavex withdraws EU marketing application for Alzheimer’s therapy blarcamesine • IH Market News • 03/25/2026 02:06:58 PM
- Anavex Life Sciences Provides Update on Regulatory Review in the EU for Blarcamesine to Treat Early Alzheimer’s Disease • GlobeNewswire Inc. • 03/25/2026 11:30:00 AM
- Anavex Life Sciences Presents New Data from its AD-004 Phase IIb/III Trial at AD/PD 2026 Conference Demonstrating Consistent Correlation Between the Treatment Effect of Oral Blarcamesine and Preservation of Brain Volume in Early Alzheimer’s Disease • GlobeNewswire Inc. • 03/23/2026 11:30:00 AM
- New Scientific Findings Highlight Hypothesis of Autophagy Failure as a Precursor of Amyloid Beta and Tau Pathology in Alzheimer’s Disease • GlobeNewswire Inc. • 03/20/2026 11:30:00 AM
- Anavex Life Sciences Presents Significant Treatment Effects of Blarcamesine in New Advanced Alpha-Synuclein Model of Parkinson’s Disease at AD/PD 2026 Conference • GlobeNewswire Inc. • 03/17/2026 11:30:00 AM
- Anavex Life Sciences to Present at the Citizens Life Sciences Conference • GlobeNewswire Inc. • 03/03/2026 12:30:00 PM
- Anavex Life Sciences to Present at the 46th TD Cowen Annual Health Care Conference • GlobeNewswire Inc. • 02/25/2026 12:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/25/2026 11:07:01 AM
- Anavex Life Sciences Appoints Seasoned Healthcare Leader to Board of Directors • GlobeNewswire Inc. • 02/23/2026 12:30:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 02/09/2026 09:40:27 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/09/2026 12:31:17 PM
